Harry F. Hixson, Jr.
2015
In 2015, Harry F. Hixson, Jr. earned a total compensation of $482.8K as Director and Former Interim Chief Executive Officer and Principal Financial Officer at Arena Pharmaceuticals, a 119% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $75,000 |
|---|---|
| Salary | $187,965 |
| Stock Awards | $164,996 |
| Other | $54,847 |
| Total | $482,808 |
Hixson received $188K in salary, accounting for 39% of the total pay in 2015.
Hixson also received $75K in non-equity incentive plan, $165K in stock awards and $54.8K in other compensation.
Rankings
In 2015, Harry F. Hixson, Jr.'s compensation ranked 10,980th out of 13,638 executives tracked by ExecPay. In other words, Hixson earned more than 19.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,980 out of 13,638 | 20th |
Division Manufacturing | 4,197 out of 5,190 | 19th |
Major group Chemicals And Allied Products | 1,543 out of 1,854 | 17th |
Industry group Drugs | 1,273 out of 1,528 | 17th |
Industry Pharmaceutical Preparations | 991 out of 1,182 | 16th |
Source: SEC filing on April 28, 2017.
Hixson's colleagues
We found six more compensation records of executives who worked with Harry F. Hixson, Jr. at Arena Pharmaceuticals in 2015.
2015
Jack Lief
Arena Pharmaceuticals
Chief Executive Officer
2015
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2015
Steven Spector
Arena Pharmaceuticals
General Counsel
2015
William Shanahan
Arena Pharmaceuticals
Chief Medical Officer
2015
Craig Audet
Arena Pharmaceuticals
Former Senior Vice President, Operations and Head of Global Regulatory Affairs
2015
Robert Hoffman
Arena Pharmaceuticals